Immediate Impact

2 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Natural killer cell therapies
2024 StandoutNature
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
3 intermediate papers

Works of Helen Parry being referenced

Extended interval BNT162b2 vaccination enhances peak antibody generation
2022
A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
2017

Author Peers

Author Last Decade Papers Cites
Helen Parry 261 231 102 352 295 49 1.3k
Randi Isaacs 215 105 67 581 570 41 1.6k
Samuel H. Pepkowitz 373 222 58 195 206 54 1.5k
Patricia Guevara‐Ramírez 191 135 123 452 256 84 1.6k
Anne Ricksten 198 76 103 284 655 58 1.7k
Rainard Fuhr 432 90 75 449 132 46 1.4k
Masaru Ido 241 112 65 276 198 79 1.1k
Magnus Hansson 554 58 41 279 216 42 1.6k
M. Tarek Elghetany 442 141 51 376 248 73 1.6k
Christophe Legendre 312 52 34 457 239 58 1.6k
Anastasia Konstantinidou 110 71 72 526 233 80 1.5k

All Works

Loading papers...

Rankless by CCL
2026